Skip to content
10-Q

Quarterly Report

Rejuvel Bio-Sciences, Inc.

0001469709-14-000336

← back to feed
Filed
Aug 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 13, 2014 118.58M sh
Operating Cash Flow Q2 2014 · Jun 30, 2014 −$1.46M
Operating Cash Flow Q2 2014 · Jun 30, 2013 −$144.48K
Stockholders Equity Q2 2014 · Jun 30, 2014 −$1.15M
Stockholders Equity Q2 2014 · Dec 31, 2013 −$1.1M
Current Liabilities Q2 2014 · Jun 30, 2014 $1.44M
Current Liabilities Q2 2014 · Dec 31, 2013 $1.21M
Total Liabilities Q2 2014 · Jun 30, 2014 $1.44M
Total Liabilities Q2 2014 · Dec 31, 2013 $1.21M
Current Assets Q2 2014 · Jun 30, 2014 $269.36K
Current Assets Q2 2014 · Dec 31, 2013 $84.66K
Total Assets Q2 2014 · Jun 30, 2014 $289.97K
Total Assets Q2 2014 · Dec 31, 2013 $105.97K
Eps Diluted Q2 2014 · Jun 30, 2014 $0.01
Eps Diluted Q2 2014 · Jun 30, 2014 −$0.01
Eps Diluted Q2 2014 · Jun 30, 2013 $0.00
Eps Diluted Q2 2014 · Jun 30, 2013 $0.00
Eps Basic Q2 2014 · Jun 30, 2014 $0.01
Eps Basic Q2 2014 · Jun 30, 2014 −$0.01
Eps Basic Q2 2014 · Jun 30, 2013 $0.00
Eps Basic Q2 2014 · Jun 30, 2013 $0.00
Sga Expense Q2 2014 · Jun 30, 2014 $1.78M
Sga Expense Q2 2014 · Jun 30, 2013 $149.04K
Sga Expense Q2 2014 · Jun 30, 2013 $287.7K
Net Income Q2 2014 · Jun 30, 2014 −$2.48M
Net Income Q2 2014 · Jun 30, 2013 −$139.13K
Net Income Q2 2014 · Jun 30, 2013 −$327.56K
Operating Income Q2 2014 · Jun 30, 2014 −$1.72M
Operating Income Q2 2014 · Jun 30, 2013 −$129.37K
Operating Income Q2 2014 · Jun 30, 2013 −$263.43K
Gross Profit Q2 2014 · Jun 30, 2014 $66.17K
Gross Profit Q2 2014 · Jun 30, 2013 $19.67K
Gross Profit Q2 2014 · Jun 30, 2013 $24.27K
Cost Of Revenue Q2 2014 · Jun 30, 2014 $40.19K
Cost Of Revenue Q2 2014 · Jun 30, 2013 $1.81K
Cost Of Revenue Q2 2014 · Jun 30, 2013 $7.26K
Revenue Q2 2014 · Jun 30, 2014 $106.36K
Revenue Q2 2014 · Jun 30, 2013 $21.48K
Revenue Q2 2014 · Jun 30, 2013 $31.53K
Shares Diluted Q2 2014 · Jun 30, 2013 117.25M sh
Shares Diluted Q2 2014 · Jun 30, 2013 117.25M sh
Cash And Equivalents Q2 2014 · Jun 30, 2013 $1.3K
Cash And Equivalents Q2 2014 · Dec 31, 2012 $120.7K
Cash And Equivalents Q2 2014 · Oct 15, 2009 $0